MeCP2 and MBD2 Expression in Breast Tissue and Its Link to Oestrogen Receptor Status
Author Information
Author(s): H M Müller, H Fiegl, G Goebel, M M Hubalek, A Widschwendter, E Müller-Holzner, C Marth, M Widschwendter
Primary Institution: University Hospital of Innsbruck
Hypothesis
What is the relationship between the expression levels of MeCP2 and MBD2 in human breast tissue and oestrogen receptor status?
Conclusion
The study found a strong association between MeCP2 mRNA expression and oestrogen receptor status in breast cancer specimens.
Supporting Evidence
- MeCP2 mRNA expression levels were significantly higher in breast cancer specimens compared to non-neoplastic lesions.
- There was a strong correlation between MeCP2 and MBD2 mRNA expression levels in both tissue types.
- MeCP2 mRNA levels predicted tissue type independent of age.
Takeaway
This study looked at two proteins, MeCP2 and MBD2, in breast tissue to see how they relate to breast cancer and hormone receptors. They found that higher levels of MeCP2 are linked to better cancer outcomes.
Methodology
The expression levels of MeCP2 and MBD2 were analyzed using quantitative real-time PCR in breast cancer specimens and non-neoplastic breast tissue.
Potential Biases
Potential biases may arise from the selection of tissue samples and the methods used for RNA extraction and analysis.
Limitations
The study's sample size for certain groups was small, which may limit the statistical power of some findings.
Participant Demographics
The mean age at diagnosis for non-neoplastic patients was 43.7 years, and for breast cancer patients, it was 62.9 years.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website